We demonstrated that EGCG attenuated myocardial fibrosis and heart failure by the suppressing endoglin and the JNK/AP‐1 pathway, and the anti‐inflammatory results suggested that it had the strong implications in controlling human cardiovascular diseases. This evidence concerns the gene ENG and cardiovascular disorder.